Phathom Pharmaceuticals, Inc. PHAT

Latest FY: 2025 Healthcare Biotechnology
Market Price $9.05
Market Cap $721.79M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑216.9% YoY
$175.11M
Full year reported
Net Income ↑33.8% YoY
-$221.25M
Net Margin: -126.3%
Free Cash Flow ↑37.4% YoY
-$167.00M
FCF Yield: -23.14%
EPS (Diluted) ↑42.7% YoY
$-3.03
Basic: $-3.03
Return on Equity Efficiency
N/A
ROA: -85.4%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (PHAT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $-0.0M $-1.3M $-0.21 $-1.0M $-1.4M
FY 2019 $1.1M $-99.3M $-255.1M -19,708.3% $-22.45 -10,590.5% 0.00% $-36.5M $-36.6M -2,590.3%
FY 2020 $1.1M +0.2% $-98.1M $-129.1M +49.4% $-3.88 +82.7% 0.00% $-69.7M $-70.7M -93.0%
FY 2021 $0.0M -96.2% $-72.3M $-143.9M -11.5% $-3.89 -0.3% 0.00% $-148.6M $-148.9M -110.6%
FY 2022 -100.0% $-197.7M -37.4% $-5.05 -29.8% 0.00% $-146.5M $-147.6M +0.9%
FY 2023 $0.7M $0.5M $-201.6M -2.0% $-3.93 +22.2% 0.00% $-137.6M $-139.2M +5.7%
FY 2024 $55.3M +8,001.5% $47.3M $-334.3M -65.8% $-5.29 -34.6% 0.00% $-266.8M $-266.9M -91.7%
FY 2025 $175.1M +216.9% $107.0M $-221.2M +33.8% $-3.03 +42.7% 0.00% $-166.8M $-167.0M +37.4%
$

Valuation

Market Price $9.05
Market Cap $721.79M
Enterprise Value $800.91M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -23.14%
Dividend Yield N/A
Shares Outstanding 79,756,000
%

Profitability & Margins

Gross Margin 61.10%
Operating Margin -91.36%
Net Margin -126.35%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -85.37%
Asset Turnover 0.68x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 1.73
Cash Ratio 0.98
Debt / Equity -0.477
Debt / Assets 0.807
Cash & Equivalents $129.97M
Total Debt $209.09M
Book Value / Share $-5.49
💧

Cash Flow Efficiency

Operating Cash Flow -$166.78M
Capital Expenditures (CapEx) $229.00K
Free Cash Flow -$167.00M
OCF / Revenue -95.24%
FCF / Revenue -95.37%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-3.03
EPS (Basic) $-3.03
Dividends / Share N/A
Book Value / Share $-5.49
EPS YoY Growth 42.72%
🏛️

Balance Sheet (FY 2025)

Total Assets $259.15M
Total Liabilities $697.32M
Stockholders' Equity -$438.17M
Current Assets $228.97M
Current Liabilities $132.04M